These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28115216)

  • 1. Myb-like, SWIRM, and MPN domains 1 (MYSM1) deficiency: Genotoxic stress-associated bone marrow failure and developmental aberrations.
    Bahrami E; Witzel M; Racek T; Puchałka J; Hollizeck S; Greif-Kohistani N; Kotlarz D; Horny HP; Feederle R; Schmidt H; Sherkat R; Steinemann D; Göhring G; Schlegelbeger B; Albert MH; Al-Herz W; Klein C
    J Allergy Clin Immunol; 2017 Oct; 140(4):1112-1119. PubMed ID: 28115216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vivo genetic reversion highlights the crucial role of Myb-Like, SWIRM, and MPN domains 1 (MYSM1) in human hematopoiesis and lymphocyte differentiation.
    Le Guen T; Touzot F; André-Schmutz I; Lagresle-Peyrou C; France B; Kermasson L; Lambert N; Picard C; Nitschke P; Carpentier W; Bole-Feysot C; Lim A; Cavazzana M; Callebaut I; Soulier J; Jabado N; Fischer A; de Villartay JP; Revy P
    J Allergy Clin Immunol; 2015 Dec; 136(6):1619-1626.e5. PubMed ID: 26220525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful allogeneic stem cell transplantation with fludarabine-based reduced intensity conditioning in bone marrow failure syndrome 4.
    Barhoom D; Mohseni R; Behfar M; Hamidieh AA
    Pediatr Transplant; 2021 Nov; 25(7):e14089. PubMed ID: 34302415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mysm1 expression in the bone marrow niche is not essential for hematopoietic maintenance.
    Petrov JC; Nijnik A
    Exp Hematol; 2017 Mar; 47():76-82.e3. PubMed ID: 27833034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further delineation of bone marrow failure syndrome caused by novel compound heterozygous variants of MYSM1.
    Li N; Xu Y; Yu T; Yao R; Chen J; Luo C; Wang J
    Gene; 2020 Oct; 757():144938. PubMed ID: 32640305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay of H2A deubiquitinase 2A-DUB/Mysm1 and the p19(ARF)/p53 axis in hematopoiesis, early T-cell development and tissue differentiation.
    Gatzka M; Tasdogan A; Hainzl A; Allies G; Maity P; Wilms C; Wlaschek M; Scharffetter-Kochanek K
    Cell Death Differ; 2015 Sep; 22(9):1451-62. PubMed ID: 25613381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional differences of SWIRM domain subtypes.
    Yoneyama M; Tochio N; Umehara T; Koshiba S; Inoue M; Yabuki T; Aoki M; Seki E; Matsuda T; Watanabe S; Tomo Y; Nishimura Y; Harada T; Terada T; Shirouzu M; Hayashizaki Y; Ohara O; Tanaka A; Kigawa T; Yokoyama S
    J Mol Biol; 2007 May; 369(1):222-38. PubMed ID: 17428495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development.
    Liang Y; Bhatt G; Tung LT; Wang H; Kim JE; Mousa M; Plackoska V; Illes K; Georges AA; Gros P; Henneman L; Huijbers IJ; Nagar B; Nijnik A
    Sci Rep; 2023 Jan; 13(1):338. PubMed ID: 36611064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction.
    Belle JI; Wang H; Fiore A; Petrov JC; Lin YH; Feng CH; Nguyen TTM; Tung J; Campeau PM; Behrends U; Brunet T; Leszinski GS; Gros P; Langlais D; Nijnik A
    JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32641579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deubiquitinase MYSM1 in the Hematopoietic System and beyond: A Current Review.
    Fiore A; Liang Y; Lin YH; Tung J; Wang H; Langlais D; Nijnik A
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophilic Panniculitis in a child with MYSM1 deficiency.
    Nanda A; Al-Abboh H; Zahra A; Al-Sabah H; Gupta A; Adekile AD
    Pediatr Dermatol; 2019 Mar; 36(2):258-259. PubMed ID: 30746751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual loss of p110δ PI3-kinase and SKAP (KNSTRN) expression leads to combined immunodeficiency and multisystem syndromic features.
    Sharfe N; Karanxha A; Dadi H; Merico D; Chitayat D; Herbrick JA; Freeman S; Grinstein S; Roifman CM
    J Allergy Clin Immunol; 2018 Aug; 142(2):618-629. PubMed ID: 29180244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYSM1/miR-150/FLT3 inhibits B1a cell proliferation.
    Jiang XX; Liu Y; Li H; Gao Y; Mu R; Guo J; Zhang J; Yang YM; Xiao F; Liu B; Wang C; Shen B; Chen SY; Li Z; Yang G
    Oncotarget; 2016 Oct; 7(42):68086-68096. PubMed ID: 27590507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deubiquitinase MYSM1 Is Essential for Normal Fetal Liver Hematopoiesis and for the Maintenance of Hematopoietic Stem Cells in Adult Bone Marrow.
    Förster M; Belle JI; Petrov JC; Ryder EJ; Clare S; Nijnik A
    Stem Cells Dev; 2015 Aug; 24(16):1865-77. PubMed ID: 26125289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel compound heterozygous mutation of
    Zhan X; Zhao A; Wu B; Yang Y; Wan L; Tan P; Huang J; Lu Y
    Br J Biomed Sci; 2021 Oct; 78(4):239-243. PubMed ID: 33618624
    [No Abstract]   [Full Text] [Related]  

  • 16. p53 mediates loss of hematopoietic stem cell function and lymphopenia in Mysm1 deficiency.
    Belle JI; Langlais D; Petrov JC; Pardo M; Jones RG; Gros P; Nijnik A
    Blood; 2015 Apr; 125(15):2344-8. PubMed ID: 25710881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYSM1 attenuates DNA damage signals triggered by physiologic and genotoxic DNA breaks.
    Mathias B; O'Leary D; Saucier N; Ahmad F; White LS; Russell L; Shinawi M; Smith MJ; Abraham RS; Cooper MA; Kitcharoensakkul M; Green AM; Bednarski JJ
    J Allergy Clin Immunol; 2024 Apr; 153(4):1113-1124.e7. PubMed ID: 38065233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical role of histone H2A-deubiquitinase Mysm1 in hematopoiesis and lymphocyte differentiation.
    Nijnik A; Clare S; Hale C; Raisen C; McIntyre RE; Yusa K; Everitt AR; Mottram L; Podrini C; Lucas M; Estabel J; Goulding D; ; ; Adams N; Ramirez-Solis R; White JK; Adams DJ; Hancock RE; Dougan G
    Blood; 2012 Feb; 119(6):1370-9. PubMed ID: 22184403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYSM1 Is Essential for Maintaining Hematopoietic Stem Cell (HSC) Quiescence and Survival.
    Huo Y; Li BY; Lin ZF; Wang W; Jiang XX; Chen X; Xi WJ; Yang AG; Chen SY; Wang T
    Med Sci Monit; 2018 Apr; 24():2541-2549. PubMed ID: 29694335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of Deubiquitinase 2A-DUB/MYSM1 with DNA Repair and Replication Factors.
    Kroeger C; Roesler R; Wiese S; Hainzl A; Gatzka MV
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.